Analysis of sustained efficacy of rituximab in children with new-onset nephrotic syndrome (PubMed, Zhonghua Er Ke Za Zhi) - Oct 16, 2026 - "The drug is generally well tolerated. However, some patients have an insufficient response to RTX and still require glucocorticoid induction."
Journal • Glomerulonephritis • Hematological Disorders • Nephrology • Neutropenia • Renal Disease
|
|
F Liu; G Q Qi; H D Fu; J H Mao; J J Wang; L Y Chen; Q Y Li; X J Zhang; Y Y Jin
|